Company: INDP
Filing Date: 2025-02-12
Form Type: 8-K
Source: 0001493152-25-006052
Chunk: 0

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-02-12
Form: 8-K
Item: Item 3.02
Chunk 0
---
Item       Unregistered                 

The
information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.02.

In
the Purchase Agreement, Yorkville represented to the Company, among other things, that it is an “accredited investor” (as
such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act of 1933, as amended (the “ Securities Act”)).
The securities referred to in this current report on Form 8-K are being issued and sold by the Company to Yorkville in reliance upon
the exemptions from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act and Rule 506(b)
of Regulation D promulgated thereunder.